Volume 17, Issue 6 (Nov-Dec 2023)                   mljgoums 2023, 17(6): 19-22 | Back to browse issues page

XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Rashedi F, Yazdanpour Z, Khademi F, Vaez H. Prevalence of carbapenem-resistant Metallo-Beta-Lactamase-producing Escherichia coli strains isolated from urinary tract infections. mljgoums 2023; 17 (6) :19-22
URL: http://mlj.goums.ac.ir/article-1-1462-en.html
1- School of Medicine, Zabol University of Medical Sciences, Iran
2- Department of Microbiology, School of Medicine, Zabol University of Medical Sciences, Iran
3- Department of Microbiology, School of Medicine, Ardabil University of Medical Sciences, Iran
4- Department of Microbiology, School of Medicine, Zabol University of Medical Sciences, Iran , hamidvaez@hotmail.com
Abstract:   (587 Views)
Background: Urinary tract infection (UTI) is one of the most prevalent bacterial diseases worldwide. Escherichia coli is a well-known etiological agent of UTI. The emergence and spread of metallo-beta-lactamase (MBL)-producing E. coli is a serious threat to public health.
This study aimed to investigate the antibiotic resistance pattern and prevalence of MBL-producing E. coli isolated from UTI.
Methods: From January 2020 to June 2021, 1200 urine specimens were collected from patients suspected of having UTI. Antibiotic susceptibility testing was carried out by the disk diffusion method. The prevalence of MBL (blaVIM, blaIMP, blaSPM, and blaNDM) genes was determined by the polymerase chain reaction (PCR) method.
Results: The highest susceptibility was observed against amikacin (96%) and gentamicin (95%). The isolates were mostly resistant against ampicillin (72%) and cephalothin (60%). All carbapenem-resistant isolates were MBL-positive. Based on the results of PCR, 75% of the isolates were blaNDM-positive.
Conclusion: Resistance to some antibiotics, such as ampicillin and cephalothin, was high, and their prescription must be restricted. The prevalence of MBL-producing isolates was not high; however, due to the high level of resistance against other antibiotics, continuous monitoring of MBL-producing isolates is highly essential.
Full-Text [PDF 424 kb]   (200 Downloads) |   |   Full-Text (HTML)  (93 Views)  
Research Article: Research Article | Subject: bacteriology
Received: 2021/11/15 | Accepted: 2022/01/4 | Published: 2024/02/26 | ePublished: 2024/02/26

References
1. Klein RD, Hultgren SJ. Urinary tract infections: microbial pathogenesis, host-pathogen interactions and new treatment strategies. Nat Rev Microbiol. 2020;18(4):211-26. [View at Publisher] [DOI] [PMID] [Google Scholar]
2. Wagenlehner FME, Bjerklund Johansen TE, Cai T, Koves B, Kranz J, Pilatz A, et al. Epidemiology, definition and treatment of complicated urinary tract infections. Nat Rev Urol. 2020;17(10):586-600. [View at Publisher] [DOI] [PMID] [Google Scholar]
3. Dubbs SB, Sommerkamp SK. Evaluation and Management of Urinary Tract Infection in the Emergency Department. Emerg Med Clin North Am. 2019;37(4):707-23. [View at Publisher] [DOI] [PMID] [Google Scholar]
4. Frieri M, Kumar K, Boutin A. Antibiotic resistance. J Infect Public Health. 2017;10(4):369-78. [View at Publisher] [DOI] [PMID] [Google Scholar]
5. Sunde M, Simonsen GS, Slettemeås JS, Böckerman I, Norström M. Integron, plasmid and host strain characteristics of Escherichia coli from humans and food included in the Norwegian antimicrobial resistance monitoring programs. PLoS One. 2015;10(6):e0128797. [View at Publisher] [DOI] [PMID] [Google Scholar]
6. Hooban B, Joyce A, Fitzhenry K, Chique C, Morris D. The role of the natural aquatic environment in the dissemination of extended spectrum beta-lactamase and carbapenemase encoding genes: a scoping review. Water Res. 2020;180:115880. [View at Publisher] [DOI] [PMID] [Google Scholar]
7. Aslan AT, Akova M. Extended spectrum β-lactamase producing enterobacteriaceae: carbapenem sparing options. Expert Rev Anti Infect Ther. 2019;17(12):969-81. [View at Publisher] [DOI] [PMID] [Google Scholar]
8. Peirano G, Pitout JDD. Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: Update on Molecular Epidemiology and Treatment Options. Drugs. 2019;79(14):1529-41. [View at Publisher] [DOI] [PMID] [Google Scholar]
9. Safarirad S, Arzanlou M, Mohammadshahi J, Vaez H, Sahebkar A, Khademi F. Prevalence and Characteristics of Metallo-beta-Lactamase-positive and High-risk Clone ST235 Pseudomonas aeruginosa at Ardabil Hospitals. Jundishapur J Microbiol. 2021;14(3):e115819. [View at Publisher] [DOI] [Google Scholar]
10. Liang T, Xu C, Cheng Q, Tang Y, Zeng H, Li X. Epidemiology, Risk Factors, and Clinical Outcomes of Bloodstream Infection due to Extended-Spectrum Beta-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae in Hematologic Malignancy: A Retrospective Study from Central South China. Microb Drug Resist. 2021;27(6):800-808. [View at Publisher] [DOI] [PMID] [Google Scholar]
11. Xiao T, Yang K, Zhou Y, Zhang S, Ji J, Ying C, et al. Risk factors and outcomes in non-transplant patients with extended-spectrum beta-lactamase-producing Escherichia coli bacteremia: a retrospective study from 2013 to 2016. Antimicrob Resist Infect Control. 2019;8:144. [View at Publisher] [DOI] [PMID] [Google Scholar]
12. Geerlings SE. Clinical Presentations and Epidemiology of Urinary Tract Infections. Microbiol Spectr. 2016;4(5). [View at Publisher] [DOI] [PMID] [Google Scholar]
13. Mahon C, Lehman D, Manuselis G. Text Book of Diagnostic Microbiology. 4th Ed. New York, NY, USA: Elsevier; 2011. [View at Publisher] [Google Scholar]
14. Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing. 28th ed. CLSI supplement M100. Wayne, PA: Clinical and Laboratory Standards Institute; 2018. [View at Publisher] [Google Scholar]
15. Vaez H, Moghim S, Nasr Esfahani B, Ghasemian Safaei H. Clonal Relatedness among Imipenem-Resistant Pseudomonas aeruginosa Isolated from ICU-Hospitalized Patients. Crit Care Res Pract. 2015;2015:983207. [View at Publisher] [DOI] [PMID] [Google Scholar]
16. Delarampour A, Ghalehnoo ZR, Khademi F, Vaez H. Antibiotic resistance patterns and prevalence of class I, II and III Integrons among clinical isolates of Klebsiella pneumoniae. Infez Med. 2020;28(1):64-9. [View at Publisher] [PMID] [Google Scholar]
17. Poirel L, Walsh TR, Cuvillier V, Nordmann P. Multiplex PCR for detection of acquired carbapenemase genes. Diagn Microbiol Infect Dis. 2011;70(1):119-23. [View at Publisher] [DOI] [PMID] [Google Scholar]
18. Dehghan F, Zolghadri N, Karmostaji A. Genetic Determinants of Antibiotic Resistance in Hospital and Community Isolates of Klebsiella pneumoniae and Escherichia coli. Jundishapur J Microbiol. 2017;10(5):e45678. [View at Publisher] [DOI] [Google Scholar]
19. Alizade H. Escherichia coli in Iran: An Overview of Antibiotic Resistance: A Review Article. Iran J Public Health. 2018;47(1):1-12. [View at Publisher] [PMID] [Google Scholar]
20. Ferdosi-Shahandashti E, Javanian M, Moradian-Kouchaksaraei M, Yeganeh B, Bijani A, Motevaseli E, et al. Resistance patterns of Escherichia coli causing urinary tract infection. Caspian J Intern Med. 2015;6(3):148-51. [View at Publisher] [PMID] [Google Scholar]
21. European Centre for Disease Prevention and Control. Antimicrobial resistance surveillance in Europe 2015. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS- Net). Stockholm: ECDC; 2017. [View at Publisher]
22. Kiddee A, Assawatheptawee K, Na-Udom A, Treebupachatsakul P, Wangteeraprasert A, Walsh TR, et al. Risk factors for gastrointestinal colonization and acquisition of carbapenem-resistant Gram-negative bacteria among patients in intensive care units in Thailand. Antimicrob Agents Chemother. 2018;62(8):e00341. [View at Publisher] [DOI] [PMID] [Google Scholar]
23. Delarampour A, Ghalehnoo ZR, Khademi F, Delarampour M, Vaez H. Molecular detection of carbapenem-resistant genes in clinical isolates of Klebsiella pneumoniae. Ann Ig. 2019;31(4):349-55. [View at Publisher] [DOI] [PMID] [Google Scholar]
24. Moayednia R, Shokri D, Mobasherizadeh S, Baradaran A, Fatemi SM, Merrikhi A. Frequency assessment of β-lactamase enzymes in Escherichia coli and Klebsiella isolates in patients with urinary tract infection. J Res Med Sci. 2014;19(Suppl 1):S41-5. [View at Publisher] [PMID] [Google Scholar]
25. Hosseini SA, Azari AA, Danesh A. Frequency of Various Types of Beta-Lactamase Enzymes in Escherichia coli Strains Isolated From Urine Samples in Aliabad, North-east of Iran. Avicenna J Clin Microbiol Infect. 2019;6(4):106-10. [View at Publisher] [DOI] [Google Scholar]
26. Mahmoodi F, Rezatofighi SE, Akhoond MR. Antimicrobial resistance and metallo-beta-lactamase producing among commensal Escherichia coli isolates from healthy children of Khuzestan and Fars provinces; Iran. BMC Microbiol. 2020;20(1):366. [View at Publisher] [DOI] [PMID] [Google Scholar]
27. Hu X, Xu X, Wang X, Xue W, Zhou H, Zhang L, et al. Diversity of New Delhi metallo-beta-lactamase-producing bacteria in China. Int J Infect Dis. 2017;55:92-5. [View at Publisher] [DOI] [PMID] [Google Scholar]
28. Dadashi M, Yaslianifard S, Hajikhani B, Kabir K, Owlia P, Goudarzi M, et al. Frequency distribution, genotypes and prevalent sequence types of New Delhi metallo-β-lactamase-producing Escherichia coli among clinical isolates around the world: a review. J Glob Antimicrob Resist. 2019;19:284-93. [View at Publisher] [DOI] [PMID] [Google Scholar]
29. Jamal WY, Albert MJ, Rotimi VO. High Prevalence of New Delhi Metallo-β-Lactamase-1 (NDM-1) Producers among Carbapenem-Resistant Enterobacteriaceae in Kuwait. PLoS ONE. 2016;11(3):e0152638. [View at Publisher] [DOI] [PMID] [Google Scholar]
30. Cetinkol Y, Sandalli C, Calgin MK, Yildirim AA, Akyildiz E, Karaman E, et al. High prevalence of NDM metallo-β-lactamase among ESBL-producing Escherichia coli isolates. Acta Microbiol Immunol Hung. 2017;64(2):131-41. [View at Publisher] [DOI] [PMID] [Google Scholar]
31. Aung MS, San N, Maw WW, San T, Urushibara N, Kawaguchiya M. Prevalence of extended-spectrum beta-lactamase and carbapenemase genes in clinical isolates of Escherichia coli in Myanmar: dominance of bla NDM-5 and emergence of bla OXA-181. Microb Drug Resist. 2018;24(9):1333-44. [View at Publisher] [DOI] [PMID] [Google Scholar]
32. Suay-García B, Pérez-Gracia MT. Present and Future of Carbapenem-resistant Enterobacteriaceae (CRE) Infections. Antibiotics. 2019;8(3):122. [View at Publisher] [DOI] [PMID] [Google Scholar]
33. Rolain JM, Parola P, Cornaglia G. New Delhi metallo-beta-lactamase (NDM-1): towards a new pandemia? Clin Microbiol Infect. 2010;16(12):1699-701. [View at Publisher] [DOI] [PMID] [Google Scholar]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2007 All Rights Reserved | Medical Laboratory Journal

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.